Background and objective: The high-affinity IgE receptor comprises a tetramer of the ligandbinding alpha chain, a signal-augmenting beta chain, and a signal-transducing gamma chain dimer on mast cells. We hypothesized that the three subsets of the FCER1 gene may play a role in the development of the aspirin-intolerant asthma (AIA) phenotype and analyzed these genetic polymorphisms in association with clinical parameters in AIA patients. Subjects and methods: Six polymorphisms of FCER1 (FCERIA-344C>T, FCER1A-95T>C, MS4A2-109T>C, MS4A2 E237G, FCER1G-237A>G, FCER1G-54G>T) were genotyped in 126 AIA patients compared to 177 patients with aspirin-tolerant asthma (ATA) and 222 normal health controls (NC). Results: A significant difference in the genotype frequencies of FCER1G-237A>G was detected between AIA and ATA patients (p < 0.05) both in co-dominant and recessive analysis models, whereas no significant relationships were identified between the frequencies of the other five single-nucleotide polymorphisms and AIA, ATA, and NC subjects. In addition, AIA patients carrying the homozygous AA genotype of FCER1G-237A>G exhibited significantly higher total serum IgE levels than did those with the GG/AG genotype (p Z 0.012). AIA patients expressing the CT/TT genotype at FCERIA-344C>T showed a higher prevalence of serum IgE specific to Staphylococcal enterotoxin A than did those with the CC genotype (p Z 0.008). Conclusion: The FCER1G-237A>G and FCERIA-344C>T polymorphisms may contribute to the development of AIA in a Korean population. ª 2008 Elsevier Ltd. All rights reserved. 
Introduction
Aspirin-intolerant asthma (AIA) is a clinically distinct syndrome characterized by the onset of asthma attacks following the ingestion of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs). Symptoms of AIA include aspirin sensitivity, asthma, and rhino sinusitis. AIA is observed in 5e15% of adult asthmatic patients and is most commonly observed in middle-aged females whose clinical symptoms are more severe than those of aspirin-insensitive asthma patients. 1e3 IgE is thought to play a key role in the pathogenesis of asthma and other allergic diseases because elevated serum IgE levels have been closely associated with atopy and allergic asthma. 4 AIA patients, however, have been shown to exhibit increased levels of serum total and specific IgE to Staphylococcal superantigens independent of atopic status. AIA patients having high serum specific IgE antibody also showed increased airway hyper responsiveness to methacholine. 5 The other study showed that IgE antibodies specific for Staphylococcal enterotoxin A (SEA) and Staphylococcal enterotoxin B (SEB) were present in approximately one half of polyp tissues from patients with nasal polyposis and the presence of enterotoxin-specific IgE correlated with the presence of polyclonal IgE antibodies specific for inhaled allergens. Furthermore, SEA and SEB positive samples were found to have eosinophils, IL-5, eotaxin and cys-leukotrienes and they were more likely to be associated with asthma or aspirin sensitivity. 6 We have also reported that the levels of SEA and SEB specific IgE antibodies in nasal polyps were higher in AIA than those with ATA and the levels of enterotoxin-specific IgE correlated with the degree of eosinophilic inflammation. 7 During the IgE-mediated response, IgE binds with a high-affinity IgE receptor, which consists of a tetramer of a ligand-binding a chain, a signalaugmenting b, and a signal-transducing g chain dimer. The receptor is abundantly expressed on the surface of mast cells and basophils and is thought to be involved in allergic inflammation of the asthmatic airway. 8 The FCER1G gene is located on chromosome 1q23 in humans. Fc3R1g plays an essential role in the induction of mast cell degranulation and survival. 9e11 To date, the only study suggesting an association of Fc3R1g with asthma and allergic diseases reported a statistically insignificant association of an FCER1G gene polymorphism with systemic lupus erythematosus. 12 The FCER1A gene is located on chromosome 1q23 and known as the first IgE-binding site to induce mast cell activation. This initiates receptor stabilization, which is critical to the IgE-mediated allergic response. 13 Although some studies have suggested a possible role of this genetic polymorphism in allergic asthma and atopic dermatitis, 14, 15 no published data support any association with AIA patients.
The MS4A2 gene, the b chain of the high-affinity receptor for immunoglobulin (IgE), is located on chromosome 11q13. The b chain of Fc3R1 is an amplifier for cell surface expression in association with the alpha chain, as well as an enhancer for signal-transduction via an immunoreceptor tyrosine activation motif (ITAM) of the Fc3RI gamma chain. 16 The MS4A2 gene polymorphism is associated with atopy, asthma, and serum total IgE in asthmatic patients. 17, 18 One study reported an association of MS4A2 gene polymorphism with the prevalence of serum IgE specific to Staphylococcal superantigens in AIA patients. 19 We examined whether genetic polymorphisms of FCER1 in mast cells play an important role in AIA pathogenesis by analyzing the genotypes and haplotypes of three subsets of FCER1 genes in association with various clinical parameters. We also investigated the possible genetic/environmental component of AIA development by examining the prevalence of serum IgE specific for three Staphylococcal superantigens: SEA, SEB, and toxic shock syndrome toxin 1 (TSST-1).
Materials and methods

Study subjects
The three study groups of 126 patients with AIA, 177 patients exhibiting aspirin-tolerant asthma (ATA), and 222 normal health controls (NC) were recruited from Ajou University Hospital, Suwon, Korea. The diagnosis of AIA was based on a positive response to a lysine-acetyl salicylic acid (ASA) bronchoprovocative test, which was performed on all study subjects according to a previously described method. 20 Change of forced expiratory volume (FEV 1 ) in 1 s was followed up for 5 h following the final dose of the aspirin challenge. The ASA-induced change (%) in FEV 1 was calculated as the percentage of post-challenge FEV 1 relative to pre-challenge FEV 1 .
Methacholine bronchial challenge tests were performed as described previously. 21 NC individuals were chosen from the general population using a screening questionnaire in which they indicated no history of respiratory symptoms or aspirin hypersensitivity. All NC subjects also exhibited an FEV 1 greater than 80% of predicted, provocation concentration (PC20) methacholine greater than 25 mg/ml, and normal findings on simple chest radiograms. Atopy was defined as one or more positive reactions in a skin prick test using 12 common aeroallergens (Bencard, Brendford, UK), with histamine and saline controls. To measure specific IgE, venous blood was collected from the antecubital vein, allowed to clot for 1e3 h at 4 C and centrifuged at 1500 Â g for 10 min at 4 C. The serum was aspirated, separated and stored in aliquots at À20 C until analysis. Serum total IgE, SEA, SEB, and TSST-1 were measured using the UniCAP system (Pharmacia Diagnostics, Valinge, Sweden), according to the manufacturer's instructions. The threshold cut off value for specific IgE level is 0.35 KU/L as measured by UniCAP.
The presence of rhinosinusitis and nasal polyps was evaluated using a paranasal sinus X-ray and rhinoscopy. Informed consent was obtained from all subjects, and the institutional review board of Ajou University Hospital (Suwon, Korea) approved the study.
SNP identification and genotyping
The single-nucleotide polymorphisms (SNPs) FCERIA-344C>T, FCERIA-95T>C, MS4A2-109T>C, and MS4A2 E237G were described previously for a Korean population. 19, 24 Briefly, genomic DNA was obtained from 40 healthy Korean volunteers. Promoter regions were sequenced to examine SNPs by using the ABI Prism 3100 DNA analyzer (Applied Biosystems, Foster City, CA, USA). Sequencing analysis was based on GenBank sequences. Sequence variants were verified using chromatograms.
SNPs in the promoter region of FCERIG were screened by SNP-ITä assays. Information regarding SNPs in the promoter region of Fc3RIG was obtained from the NCBI SNP database and two SNPs were selected.
SNP genotyping was performed using SNP-ITä assays with the SNPstream 25Kä system (Orchid Biosciences, Princeton, NJ, USA). The region of genomic DNA spanning the polymorphic site was amplified using PCR with one phosphothiolated primer and one regular PCR primer. The sequences of the amplifying and extension primers for FCERIA-344C>T (rs 2427827), FCERIA-95T>C (rs 2251746), MS4A2-109T>C (rs 1441586) MS4A2 E237G (rs 569108), FCERIG-237A>G (rs 11587213), and FCERIG-54G>T (rs 2070901) were shown (Table 1) . BIONEER (http://www.bioneer. com) programme was used for primer composition and further verified by NCBI BLAST (http://www.ncbi.nlm.nih. gov/blast/Blast.cgi).
Statistical analysis
Significant departures of genotype frequency from Hardye Weinberg equilibrium at each polymorphic site were tested using chi-square analyses. Haplotypes of the Fc3RI gene were analyzed using Haploview v2.0 based on the Pairwise linkage disequilibrium (LD) between SNP loci was measured using the absolute value of Lewontin's D 0 and r 2 . 23 Differences in the mean values of phenotypic characteristics among AIA patients were compared using analysis of t-tests. Statistical analyses were performed using SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) with a significance level of p < 0.05. Values in bold indicate significant p value. *q Z minor allele frequency.
Results
Clinical characteristics of the study subjects
The mean ages of both AIA and ATA patients were significantly higher than that of the NC group (p < 0.001; Table 2 ). The atopy rate was significantly lower for AIA patients compared to those with ATA (p Z 0.026). The percent fall in forced expiratory volume (FEV 1 ) after the lysine aspirin inhalation was significantly lower in the AIA patients compared to the ATA patients (p Z 0.001). The AIA patients also exhibited significantly lower baseline PC20 methacholine compared to the ATA patients (p < 0.001). Significant differences in serum total IgE were noted for both the AIA and ATA patients compared to the NCs; however, there was no significant difference in serum total IgE between AIA and ATA patients.
Allele, genotype, and haplotype frequencies of the FCER1 gene with the AIA phenotype Genetic associations were examined among the six genetic polymorphisms of FCERIA-344C>T, FCERIA-95T>C, MS4A2-109T>C, MS4A2 E237G, FCERIG-237A>G, and FCERIG-54G>T and the three study groups of AIA, ATA, and NC. The genotype distribution of six polymorphisms did not depart significantly from HardyeWeinberg equilibrium (p>0.05). The genotypic frequency of FCERIG-237A>G was significantly different between AIA and ATA patients (Table 3) . Specifically, AIA patients showed a significantly higher frequency of the homozygous AA genotype of FCERIG-237A>G compared to ATA patients (p < 0.05) both in co-dominant and recessive analysis models. However, there were no significant differences among the test groups with respect to the allele and genotype frequencies of the other FCERI SNPs, including FCERIA-344C>T, FCERIA-95T>C, MS4A2-109T>C, MS4A2 E237G, and FCERIG-54G>T (p>0.05) ( [GG] were constructed utilizing the EM algorithm. No significant differences in haplotypes frequencies were observed among the three groups (p>0.05) (data not shown). In addition, there were no significant associations between clinical parameters such as atopy, FEV 1 , log PC20 methacholine, and rhinosinusitis and any polymorphism within the AIA patients.
FCERIG-237A>G and total serum IgE levels
Of the six target SNPs of the Fc3RI gene, a significant association was detected between the FCERIG-237A>G polymorphism and total serum IgE level in AIA patients. In addition, AIA patients carrying the homozygous AA genotype of FCERIG-237A>G exhibited significantly higher levels of total serum IgE than did those with the AG/GG genotype (p Z 0.012) ( Table 4 ). This association was not found in ATA patients (p>0.05, data not shown). Furthermore, no significant associations were found between the total serum IgE level and the other five SNPs, including FCERIG-54G>T, FCERIA-344C>T, FCERIA-95T>C, MS4A2-109T>C, MS4A2 E237G, and FCERIG-54G>T (Tables 4e6). (Tables 4e6). Significant associations were noted between two SNPs, i.e., FCERIA-344C>T and FCERIA-95T>C, and the prevalence of serum IgE specific to SEA. Specifically, AIA patients carrying the CT/TT genotype at FCERIA-344C>T had a significantly higher prevalence of SEA-specific IgE than did those with the CC genotype (p Z 0.008). In addition, AIA patients with the CT/CC genotype at FCERIA-95T>C had a higher prevalence of SEAspecific IgE than did those with the TT genotype (p Z 0.035). The FCERIA-95T>C genetic polymorphism was also significantly associated with the prevalence of IgE specific for TSST-1, whereby patients carrying the CT/CC genotype exhibited a significantly higher prevalence than those with the homozygous TT genotype (p Z 0.036; Table 5 ).
However, no such associations were found in case of ATA patients (p>0.05; data not shown). AIA patients expressing the TT genotype of the MS4A2-109T>C genetic polymorphism showed a significantly higher prevalence of IgE specific for SEB than did those with CT/CC genotype (p Z 0.012). There was no association between the MS4A2 E237G polymorphism and IgE specific for SEA, SEB, or TSST-1 (Table 6 ).
Discussion
We examined six genetic polymorphisms of FCER1A, MS4A2, and FCER1G for associations with the AIA phenotype in a Korean population. The FCER1G-237A>G was significantly associated with the AIA phenotype, as well as total serum IgE levels, within AIA patients. Fc3R1g is essential for initiating the signal-transduction pathway necessary to induce cell degranulation, although its intensity is less than that of endogenous tetrameric Fc3R1. 10 The promotion of mast cell survival by IgE without antigens is mediated by signals through the ITAM. Therefore, Fc3R1g-mediated signals differentially upregulate the receptor expression, activation, and survival of mast cells. 10 No study has examined the genetic association of this polymorphism with the pathogenic mechanism of AIA, however, recent data suggest that mRNA levels of Fc3R1g in peripheral blood mononuclear cells are upregulated by aspirin treatment. 25 Even though serum total IgE may be more important for asthma rather than AIA, our present statistical significant association of FCER1G-237A>G and serum total IgE in AIA group cannot be precluded. Therefore, functional role of this SNP might be beneficial for AIA pathogenesis. Given our results, we propose that the FCER1G-237A>G polymorphism may be a risk factor for AIA susceptibility.
We previously demonstrated a significant association of FCER1A with aspirin-intolerant chronic urticaria, 24 in which an FCER1A promoter polymorphism was associated with increased expression of Fc3R1a on mast cells via the enhanced release of histamine. Similarly, the study also indicated that the FCER1A-344C>T is associated with total serum IgE levels in patients with allergic diseases. 26 However, we did not find any significant association between allelic frequencies of FCER1A-344C>T with the total serum IgE level within the AIA patients, but a significant association was detected between FCER1A-344C>T and the prevalence of SEA-specific serum IgE. Functional role of FCER1A-344C>T implicated that the reporter plasmid carrying -344T allele exhibited significantly higher promoter activity in a rat mast cell line (RBL-2H3) compared to -344C allele. The association of transcription factor Mycassociated zinc finger protein bound the -344C promoter and also showed that heterozygous CT genotype of the -344C>T exhibited greater anti-IgE-mediated histamine release compared to CC genotype. 24 Although, we identified significant associations between the FCER1A-95T>C polymorphism and serum IgE specific for SEA and TSST-1, further studies using a larger sample size are necessary to confirm these associations.
Previous population studies have reported significant associations between the MS4A2 polymorphism and total serum IgE levels in asthmatic patients. 27, 28 However, our results suggest that this is not the case for AIA patients.
Kim et al. 19 suggested a synergistic effect between the MS4A2-109T>C polymorphism and serum IgE specific to SEB in AIA patients. These results were supported by our current study population. It has been proposed that this genetic/environmental interaction occurs via the binding of SEB-specific IgE to its high-affinity receptor Fc3R1 on the mast cell surface, resulting in mast cell activation and the enhanced release of inflammatory mediators and cytokines, which could ultimately contribute to AIA development. In vitro functional study of MS4A2-109T>C by luciferase reporter assays showed that Fc3R1b-109T allele was associated with higher promoter activity in both RBL-2H3 and A549 cell lines. 19 Therefore, increased expression of Fc3R1b-109T on mast cells may enhance the inflammatory mediators and Th2 cytokines and development of AIA.
With respect to the role of Staphylococcal superantigens in AIA pathogenesis, it is possible that AIA patients with high levels of IgE specific for the three Staphylococcal superantigens exhibit more severe airway hyperresponsiveness. 8 Specifically, the Staphylococcal superantigens may stimulate mast cell activation and polyclonal activation of T cells and antigen-specific CD4 þ T cells with the release of Th2 cytokines and other proinflammatory mediators. This would promote the activation of IgE-producing B cells, which could contribute to the development of airway inflammation in AIA patients. 29, 30 Given our data, we suggest that two genetic polymorphisms, FCER1A-344C>T and MS4A2-109T>C, may interact with the specific IgE response to Staphylococcus aureus, which enhances the progression of airway inflammation in AIA patients.
In conclusion, we examined three sets of FCER1A, MS4A2 and FCER1G genetic polymorphism in AIA patients comparing with ATA and NC. Among them, FCERIG-237A>G may be more susceptible in AIA in a Korean population in association with serum total IgE and it is also speculated that FCER1A-344C>T and MS4A2-109T>C may increase the severity of AIA in association with specific IgE responses to Staphylococcal superantigens. 
